Abstract
Monitoring of nitric oxide (NO) and nitrogen dioxide (NO2) is a prerequisite for the clinical use of NO. Chemiluminescence, the reference method, cannot be used as a routine in clinical practice in view of its cost and other restraints. This study was performed to evaluate a device using an electrochemical method (Polytrons NO and NO2, Dräger®). Forty-nine simultaneous measurements of NO and various oxides of nitrogen (NOx) concentrations by the two apparatus were performed. NO measurements by means of these two methods are very well correlated (r=0.96;p<10–5). The mean difference according to the method of Bland and Altman was 2.8±1.7 ppm, with the limits of agreement at −0.6 and +6.2 ppm (confidence interval of 95%). There was also a good correlation between measurements of NO2 obtained via Polytrons and NOx via chemiluminescence (r=0.84;p<10−5). However, NO2 measurements obtained via Polytron may be insufficient to exclude potential toxicity of NO2 due to the inability to detect measurements in the ppbrange. This study demonstrates that devices designed for industrial purposes (Polytrons NO and NO2, Dräger®) can be used for clinical purposes.
Article PDF
Similar content being viewed by others
References
Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilatator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038–2047
Fratacci MD, Frostell C, Chen TY, Wain JC, Robison DR, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilatator of heparin protamine vasoconstriction in sheep. Anesthesiology 75:990–998
Peke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338: 1173–1174
Girard C, Lehot JJ, Pannetier JC, Filley S, French P, Estanove S (1992) Inhaled nitric oxyde after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 77:880–883
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet I:307–310
Stenqvist O, Kjelltoft B, Lundin S (1993) Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand 37: 687–691
Moutafis M, Lawkoune JD, Fischler M (1992) NO2 concentration during inhalation of NO in pigs. Anesthesiology 77:A1230
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405
Foubert L, Fleming B. Latimer R, Jonas M, Oduro A, Borland C, Higenbottam T (1992) Safety guidelines for use of nitric oxide. Lancet 339:1615–1616
Roberts DJ, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818–819
Kinsella JP, Neish SR, Shaffer E, Arman SH (1992) Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819–820
Morrow PE, Utell MJ, Bauer MA, Smeglin AM, Frampton MW, Cox C, Speers DM, Gibb FR (1992) Pulmonary performance of elderly normal subjects with chronic obstructive pulmonary disease exposed to 0.3 ppm nitrogen dioxide. Am Rev Respir Dis 145:291–300
Davis JK, Davidson MK, Schoeb TR, Lindsey JR (1992) Decreased intrapulmonary killing of Mycoplasmapulmonis after short-term exposure to NO2 is associated with damaged alveolar macrophages. Am Rev Respir Dis 145:406–411
Goldstein E, Peek NF, Parks NJ, Hines HH, Steffey EP, Tarkington B (1977) Fate and distribution of inhaled nitrogen dioxide in rhesus monkeys. Am Rev Respit Dis 115:403–412
Stamler JS, Singel DJ, Loscalzo J (1992) Biochemistry of nitric oxide and its redox-activated form. Science 258: 1898–1902
Frampton MW, Morrow PE, Cox C, Gibb FR, Speers DM, Utell MJ (1991) Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans. Am Rev Respir Dis 143:522–527
Dreyfuss D, Basset G, Soler P, Saumon G (1985) Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 132:880–884
Klein J (1990) Normobaric pulmonary oxgen toxicity. Anesth Analg 70: 195–207
Patel JM, Block ER (1986) Nitrogen dioxide-induced changes in cell membrane fluidity and function. Am Rev Respir Dis 134:1196–1202
Rasmussen TR, Kjaergaard SK, Tarp U, Pedersen OF (1992) Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis 145: 654–659
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moutafis, M., Hatahet, Z., Castelain, M.H. et al. Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations. Intensive Care Med 21, 537–541 (1995). https://doi.org/10.1007/BF01706209
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01706209